Vania Vidimar

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Escherichia Coli

Rheumatoid Arthritis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Vania Vidimar, Minyoung Park, Caleb K Stubbs, Nana K Ingram, Wenan Qiang, Shanshan Zhang, Demirkan Gursel, Roman A Melnyk, Karla J F Satchell
Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts. Molecular cancer therapeutics 21 (5) (2022)
Vania Vidimar, Greg L Beilhartz, Minyoung Park, Marco Biancucci, Matthew B Kieffer, David R Gius, Roman A Melnyk, Karla J F Satchell
An engineered chimeric toxin that cleaves activated mutant and wild-type RAS inhibits tumor growth. Proceedings of the National Academy of Sciences of the United States of America 117 (29) (2020)